Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple quiz predict brain health in aging? italian study aims to find out

NCT ID NCT07533084

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test an Italian version of a questionnaire called the dynamic Neurocognitive Adaptation (dNA) scale in 265 older adults, including those with normal aging, mild memory complaints, or dementia. The goal is to see if higher scores on the scale—reflecting more engagement in physical, cognitive, creative, and social activities—are linked to better memory and brain function. Participants will complete interviews, memory tests, and questionnaires, and some will have their existing MRI scans analyzed. This is a validation study, not a treatment, so it aims to improve understanding rather than offer a direct benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a simple tool to assess how physical, cognitive, and social activities relate to brain health in aging.
What could go wrong
This is an early validation study, not a treatment trial. It only measures correlations, not cause and effect, and results may not apply outside Italy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 265 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Each of the 8 participating centers will enroll approximately at least 30 participants, specifically: * IRCCS Campus Biomedico (RM): HC, AD, MCI, SMC (approximately 5 HC, 15 patients); * IRCCS Centro San Giovanni di Dio Fatebenefratelli (BS): HC, SMC (approximately 20 HC, 10 patients); * IRCCS Fondazione Mondino (PV): HC, AD, MCI, SMC (approximately 10 HC, 40 patients); * IRCCS "Carlo Besta" Neurological Institute (MI): HC, MCI (approximately 15 HC, 15 patients); * IRCCS Neuromed (IS): HC, AD, MCI, SMC (approximately 10 HC, 20 patients); * IRCCS San Camillo Hospital (VE): HC (approximately 30 HC); * IRCCS San Raffaele Hospital (MI): HC, AD, MCI, SMC (approximately 10 HC, 20 patients); * IRCCS San Martino (GE): HC, AD, MCI, SMC (approximately 10 HC, 25 patients).

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Stage #1): * Individuals aged ≥ 65 years residing in Italy; * Cognitively healthy individuals (HC); * Individuals with subjective memory complaints (SMC); * Individuals with mild cognitive impairment (MCI); * Individuals with probable Alzheimer's disease (AD). Inclusion criteria (Stage #2 \& Stage #3): * Individuals aged ≥ 65 years residing in Italy; * Cognitively healthy individuals (HC); * Individuals with subjective memory complaints (SMC); * Individuals with mild cognitive impairment (MCI); * Individuals with probable Alzheimer's disease (AD); * Individuals with Alzheimer's disease or other forms of dementia; * Individuals suffering from mental disorders clinically diagnosed. Cognitively healthy individuals (HC): * MMSE score ≥24, or alternatively MoCA score ≥26; * No diagnosis of depression, MCI or any form of dementia; * Episodic memory performance within the normal range (Wechsler Memory Scale Logical Memory II ≥9 for 16 years of schooling or more; ≥5 for 8-15 years of schooling, ≥3 for 0-7 years of schooling; or alternatively for Prose Memory Test with scores ≥9 for ≥16 years of schooling → ≥5 items in immediate or delayed recall; ≥5 for 8-15 years of schooling → ≥3-4 items in immediate or delayed recall; ≥3 for 0-7 years of schooling → ≥2 items in immediate or delayed recall) Individuals with Subjective Memory Complaints (SMC): * MMSE score ≥24, or alternatively MoCA score ≥26; * A significant memory impairment, reported by the subject, a family member, or the clinician; * No diagnosis of depression, MCI or any form of dementia; * Episodic memory performance within the normal range on the Wechsler Memory Scale Logical Memory II adjusted for years of schooling (≥9 for 16+ years of schooling, ≥5 for 8-15 years of schooling, ≥3 for 0-7 years of schooling) or, alternatively, on the Prose Memory Test (with scores ≥9 for ≥16 years of schooling → ≥5 items in immediate or delayed recall; ≥5 for 8-15 years of schooling → ≥3-4 items in immediate or delayed recall; ≥3 for 0-7 years of schooling → ≥2 items in immediate or delayed recall) Individuals with Mild Cognitive Impairment (MCI): * MMSE score between 19 and 23 inclusive (alternatively MoCA); * A decline in memory reported by the subject, a family member, or the clinician; * No diagnosis of depression or affected by any form of dementia, with preserved ability in activities of daily living; * Objective episodic memory loss on the Wechsler Memory Scale Logical Memory II adjusted for years of schooling. Individuals with probable Alzheimer's disease (AD): * Insidious onset with atypical course: some criteria for probable AD are met, but the onset of symptoms may have been sudden, or there is a lack of objective evidence of progressive cognitive decline; * Mixed etiology presentation: All criteria for probable AD are met, with concomitant cerebrovascular disorders, or the presence of features typical of another dementia or the evidence of other neurological disorders or non-neurological comorbidities; * A decline in performance compared to the previous level of functioning is evident, as also described by a caregiver (often a family member) * Onset with memory disturbances, defined as difficulty learning new information or recalling it; * Onset with non-mnemonic symptoms (language symptoms, particularly difficulty finding the correct words; visuospatial symptoms: perceptual deficits characterized by failure to recognize objects, people, or written words; executive symptoms: difficulties with reasoning and critical thinking); * MMSE score \< 23 (alternatively MoCA \< 25); * Objective episodic memory loss on the Wechsler Memory Scale Logical Memory II adjusted for years of schooling. Exclusion criteria (Stage #1): * Individuals aged \< 65 years; * Individuals not residing in Italy; * Individuals with depression or other psychiatric disorders; * Individuals with forms of dementia other than Alzheimer's disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Active aging individuals aged 65 and over are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia Habits Motor Activity subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IRCCS Campus Bio-Medico

    Roma, RM, 00128, Italy

  • IRCCS Centro San Giovanni di Dio Fatebenefratelli

    Brescia, BS, 25125, Italy

  • IRCCS Fondazione Mondino

    Pavia, PV, 27100, Italy

  • IRCCS Istituto Neurologico Carlo Besta

    Milan, Michigan, 20133, Italy

  • IRCCS Neuromed - Istituto Neurologico Mediterraneo

    Pozzilli, IS, 86077, Italy

  • IRCCS Ospedale San Camillo

    Venezia, VE, 30126, Italy

  • IRCCS Ospedale San Raffaele

    Milan, Michigan, 20132, Italy

  • IRCCS San Martino

    Genova, GE, 16132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.